Since FHR1 helps to combat infection by out competing FH at the bacterial surface (34), it makes some sense to see an apparent increased representation of those individuals in a secondary aHUS cohort, i.e. the CFHR3-CFHR1 deletion is not only associated with increased risk of FH autoantibody. The gene discussed is CFHR3; the disease is infection.